Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dongqi Yuan
Observed names:
Dong-Qi Yuan,
Dong-qi Yuan,
Yuan Dongqi
Institution:
Tianjin Medical University Cancer Institute and Hospital
Observed institutions:
Shandong University,
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
ORCID:
0000-0002-0490-2146
Observed ORCID:
0000-0002-0490-2146
OpenAlex ID:
A5069919429
Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis
2022
·
Qi Cai
, Geng-wei Huo
, et al.
·
Human Vaccines & Immunotherapeutics
·
36
BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer
2022
·
Shunan Wang
, Xinyu Liu
, et al.
·
Disease Markers
·
21
PDF
TWF1 induces autophagy and accelerates malignant phenotype in lung adenocarcinoma via inhibiting the cAMP signaling pathway
2023
·
Yu Wang
, Ran Zuo
, et al.
·
The FASEB Journal
·
15
PDF
Detection and genetic characterization of Toxoplasma gondii in market-sold mussels (Mytilus edulis) in certain provinces of China
2019
·
Wei Cong
, Nian-Zhang Zhang
, et al.
·
Microbial Pathogenesis
·
15
High incidence and reversible bradycardia events following alectinib initiation
2022
·
Dongqi Yuan
, Fuyi Zhu
, et al.
·
Thoracic Cancer
·
12
PDF
5-HT regulates resistance to aumolertinib by attenuating ferroptosis in lung adenocarcinoma
2025
·
Yuanying Feng
, Yuchao He
, et al.
·
EMBO Molecular Medicine
·
10
PDF
Integration of Multi-Scale Profiling and Machine Learning Reveals the Prognostic Role of Extracellular Matrix-Related Cancer-Associated Fibroblasts in Lung Adenocarcinoma
2025
·
Ziyi Chen
, Mengyuan Chen
, et al.
·
International Journal of Medical Sciences
·
6
Immune-related gene risk model establishment and role of key gene FUCA1 in malignant pleural mesothelioma
2025
·
Lin Shi
, Dongqi Yuan
, et al.
·
Frontiers in Pharmacology
·
2
PDF
Safety and Efficacy of Immune Checkpoint Inhibitors in Advanced Cancer patients with Autoimmune Disease: a Meta-Analysis
2022
·
Qi Cai
, Gengwei Huo
, et al.
·
Research Square
·
2
PDF
SLC39A6 as a pan-cancer promising biomarker and actionable therapeutic target for CH5132799 sensitivity
2026
·
Li Hongmin
, Wang Yufei
, et al.
·
BMC Cancer
·
1
CAV2 Modulates Cetuximab Sensitivity in HNSCC via Ubiquitin-Mediated Disruption of the PACT-PKR Axis
2026
·
Yun Wang
, Yafei Wang
, et al.
·
Cancers
Safety and Efficacy of Immune Checkpoint Inhibitors in Advanced Cancer patients with Autoimmune Disease: a Meta-Analysis
2022
·
Qi Cai
, Geng-wei Huo
, et al.
·
Research Square
Safety and Efficacy of Immune Checkpoint Inhibitors in Advanced Cancer patients with Autoimmune Disease: a Meta-Analysis
2022
·
Peng Chen
, Qi Cai
, et al.
·
Research Square
Individualized Prognostic Score for Lung Adenocarcinoma Based on Immune Status
2022
·
Peng Chen
, Mihray Abdurazik
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
14
Citation count:
120
H-index:
6
I10-index:
6
Year
Topic
Type